Marghoob Ashfaq A
Memorial Sloan-Kettering Skin Cancer Center, Hauppauge, New York, USA.
Semin Cutan Med Surg. 2011 Dec;30(4 Suppl):S1-5. doi: 10.1016/j.sder.2011.11.003.
Skin cancers are the most common form of malignancy. Early diagnosis and treatment provides the best chance for survival and reduced morbidity. However, some patients have recurrent or resistant lesions. In patients with basal cell carcinoma (BCC), prognosis is relatively good for all four types of lesions (superficial, nodular, infiltrative, and morpheaform), but the highest recurrence rates and greatest morbidity are associated with infiltrative and morpheaform BCC, and prognosis is least favorable when perineural invasion has occurred. Research into the etiology of BCC and other skin cancers has led to the identification of several genetic mutations-those of the Patched and Hedgehog genes. By targeting these pathways, treatments aimed at driver mutations hold promise for new nonsurgical treatments.
皮肤癌是最常见的恶性肿瘤形式。早期诊断和治疗为生存及降低发病率提供了最佳机会。然而,一些患者会出现复发性或难治性病变。在基底细胞癌(BCC)患者中,所有四种类型的病变(浅表型、结节型、浸润型和硬斑病样型)预后相对良好,但浸润型和硬斑病样型基底细胞癌的复发率最高且发病率最高,当发生神经周围侵犯时预后最不理想。对基底细胞癌和其他皮肤癌病因的研究已导致鉴定出几种基因突变——即Patched和Hedgehog基因的突变。通过靶向这些途径,针对驱动突变的治疗有望成为新的非手术治疗方法。